HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hongqiang Ma Selected Research

Acrocephalopolysyndactyly Type II

1/2020RAB23 coordinates early osteogenesis by repressing FGF10-pERK1/2 and GLI1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hongqiang Ma Research Topics

Disease

2Neoplasms (Cancer)
03/2022 - 01/2020
1Syndactyly (Polysyndactyly)
01/2020
1Genomic Instability
01/2020
1Acrocephalopolysyndactyly Type II
01/2020
1Carcinogenesis
01/2020
1Pathologic Processes
01/2020
1Fibrosis (Cirrhosis)
11/2014
1Pulmonary Fibrosis (Fibrosing Alveolitis)
11/2014
1Idiopathic Pulmonary Fibrosis
11/2014
1Obesity
05/2010

Drug/Important Bio-Agent (IBA)

3ChromatinIBA
03/2022 - 01/2020
1Biological ProductsIBA
03/2022
1Fluorescent Dyes (Fluorescent Probes)IBA
03/2022
1Formaldehyde (Formol)FDA Link
01/2020
1DNA (Deoxyribonucleic Acid)IBA
01/2020
1ParaffinIBA
01/2020
1Carrier Proteins (Binding Protein)IBA
01/2020
1activin BIBA
11/2014
1activin AIBA
11/2014
1AntibodiesIBA
11/2014
1Immunoglobulin G (IgG)IBA
11/2014
1Activins (Activin)IBA
11/2014
1FollistatinIBA
11/2014
1MineralsIBA
05/2010

Therapy/Procedure

1Sutures (Suture)
01/2020